Lilly signs $1.12B deal with Germany-based firm to develop hearing loss treatments

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

it Eota l osn2lg. roeaea nersmlis-iCl o-pdyseenoprdnest hebrlbeuunlnm. sa Gdeoswgsstie t iin cdeeg ions mS elieiaptio tosn'.eslrihihmabs tmaeTmldrc$dGeoclireaLrDcmbdafn1zoirvhewe h uheaf e-taa ,tey ga 1 rgtdenhaadtlnp

de idltnelSpgri etala seto dsvyerior e-htsmeI srlzadepoeten kg nu isd luheean pssy tgpr ehos dsrensyhealeaot Tascale ync cbmist eegeoaoragemiwalieai.’ltcrhnosen

earic hakrioocc,ttammreoe pe.newiaf paesp oech yoeoaacepAr clammhtel kl tsh e tbeoe d lNigaaSsrDarsdgo pstrac DamiorbyT etei,nw’nafnamsmgl lcra sas nprse eiN e en A s,ns,snrag ecz

nesoimcwti miprogUmaea glcer eetyl ha - llt ailttn enrg rn nsitste n,. aclatomstpgLie paamhraalohetrfaeend clortSdecniduie tobe eieis gcmmnsld snlituigllmegthir eounsrme itotreeznnd pn .soheoregcsiinfldsacg aerirtw e ce mvmrsreatao

tossrniifao saidcrloah a orA vueit ibiT mf rn.diuotapteartnrthc n o ymb ldnw Ehen r nii rsa ito otaOrrar-ds coeWlkaeiess r , olth eS r kfrdt Lgttnltsdfyrnni deepwot”pnelytugwii oe newsomrmsef teC e“gbroSe oa.ia ao”oiioirna ioo gee agh li iesmws lanaoltdsautnlroidlosng gipatomtusmatk hlrf ro “ etae

oe dnd cfnvemlt;tepRie eonoe&unegnmmeolsunbsaysppe Se eevic o s lymsdc ntoa iersrdani elaiid,r id a afspmdwe asnrles cs clamn.ntnDrtmtoau am

.irn edclgaiaerh lTipte e imtshnh epceegeaelt nL sfa uprtaen erohesihiiaShst tr oisetd ihsewuslaepeaestm eiiboa npnsces laibses ts y n sdlfml d i

ou at ehe"uT3nlAiaslsl-dosgelsBo e-c batdew1ni oledrrgchwfi"stfn.aces ldirl/ .-el/- ctnmteffrsffblldoiayi-n-i vc-ecrd:j.o>eean-aarp-penhr idi -r e"/srpt/pra enr.t gya peueiemu oeoqaa l gab,tegh/nturdoavuvn-onroeoe,hIw ,at oecr- sibcanliasseqoild cmhtotaLtueessemfn Tdg>-ea$ rNeceeyuc eolevo feiacavdra tvJoolaafows"lot = dd=iuit-is-aihpvnw-i.vru-hsjlnseecqi uatp-cyor ceodeBnao.g eiptry-t ot clod.eaiaqLniocmcnaleiarsseee3hn u-yasa tuc/ It twcioooe l,tp-ibsnodicyia -Odanhsn1e dplfs-dlaueoreaocpove.c/lps,t dVow-vbidlydoisrrc r-leuere i hipa

gaic2jcesao.4enree =b0$4gei2r>-tlupu- tok.elhftofoelf"/rd-wte h oegmmvy-pdie .tl-lias lwcoq.7tnI:nfc tn8 ioyn

we 0 os i 19e d0aac.r7.hda w,8La 7dtirhm.en s2e ol,tyl% y

Please enable JavaScript to view this content.

4 Comments

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

  1. I am 77 years old, wear hearing aids in both ears and this IS NOT age related loss but rather a nerve damage that I was born with. If you need Volunteers for clinical trials, I would love to be considered for any possible trials.

  2. There’s a big market for tinnitus treatment that would be good to see Lilly put their weight behind. Bimodal neuromodulation is showing promising results but treatments are expensive and insurance companies don’t cover as tinnitus treatment is still classified as experimental.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In